On October 11th, on October 8, the Guangdong Provincial Food and Training and Food and Drug Administration issued a list of pilot approved products in Guangdong medical equipment registrant (as of 2021-10-8), Huawei wrist single-conductor electric collector officially approval Production, registration number: Yuerta 40202071705, Trustee is Yumen Co., Ltd. and Weifangjing is Gaoke Electronic Technology Co., Ltd.
It is reported that except for the wrist single-conductor electric collector, Huawei has three medical devices to enter priority approval procedures. They are wrist cardiocromogenic blood pressure recorders (MLY-B10, MLY-B11), electrocardiological analysis system (ECG-1), and heart rate malformed analysis system (PPG-1).
It is worth mentioning that in May this year, Huawei consumer business mobile phone product line president "He Gang" said that the microblog is issued, Huawei's first smart watch that can measure blood pressure has passed the medical device registration, the next step will jointly Medical institutions open registration clinical trials, which is expected to be officially launched in the second half of this year. On September 6, Huawei also recruited the blood pressure test subject through its member app, requiring the wrist circumference of more than 200 mm, and the blood pressure is higher than 140mm hg.
IT House understands that Huawei is currently using high-precision blood pressure measurement as a household medical level, developing a blood pressure measurement equipment, while Huawei launched high blood pressure management research, exploring blood pressure innovation from screening to early intervention Health management.
According to Huawei officially, Huawei Medical has already served more than 3,000 medical and health service agencies. Provide comprehensive coverage, safe controlling, operation and maintenance, and future wireless network solutions for the medical industry.